Ovid Therapeutics Inc.

OVID · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$20,611$28,415$21,136$26,301
Short-Term Investments$4,992$9,932$21,860$26,774
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,221$0$0$0
Total Curr. Assets$28,824$42,089$45,921$55,940
Property Plant & Equip (Net)$12,185$12,500$12,855$13,230
Goodwill$0$0$0$0
Intangibles$0$0$38$92
Long-Term Investments$20,908$20,908$20,908$20,974
Tax Assets$0$0$0$0
Other NC Assets$1,931$1,931$1,932$1,931
Total NC Assets$35,024$35,339$35,733$36,227
Other Assets$0$0$0$0
Total Assets$63,848$77,428$81,654$92,167
Liabilities
Payables$1,710$3,950$1,950$3,191
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$718$0$0$0
Other Curr. Liab.$0$718$0$1
Total Curr. Liab.$6,796$8,924$9,307$10,522
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$1$0
Total NC Liab.$12,354$12,715$13,071$13,419
Other Liabilities$0$0$0$0
Cap. Leases$1,409$14,099$14,430$14,755
Total Liabilities$19,150$21,639$22,378$23,941
Equity
Pref Stock$0$0$0$0
Common Stock$71$71$71$71
Retained Earnings-$331,376-$319,218-$314,533-$304,299
AOCI-$126-$69-$48-$35
Other Equity$0-$0$0-$0
Total Equity$44,698$55,789$59,276$68,226
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$63,848$77,428$81,654$92,167
Net Debt-$20,611-$28,415-$21,136-$26,301